Issue: Volume IX No. 6 - April 22, 2002

California Is Lab Industry’s Bellwether Again

IT’S NO COINCIDENCE THAT two recent lab industry developments are centered around lab companies in California. Repeatedly that state has proven to be a valuable bellwether of lab industry trends for the nation. On the lab regulatory front, state officials from the California Department of Health Services (CDHS) have sanctioned Specialty Laboratories, Inc., based upon …

California Is Lab Industry’s Bellwether Again Read More »

State, Federal Regulators Target Specialty Labs

CEO SUMMARY: Specialty Laboratories, Inc. has earned the dubious honor of being the first-ever publicly-traded laboratory to have its CLIA-88 license revoked by federal regulators, terminating its right to payment for services covered by Medicare and Medicaid. The revocation is slated to take effect on April 26, but is subject to a court appeal that …

State, Federal Regulators Target Specialty Labs Read More »

Quest Pays $1.1 Billion To Acquire Unilab Corp.

CEO SUMMARY: Quest Diagnostics Incorporated is showing its muscle. The dust had hardly settled on its $500 million acquisition of American Medical Laboratories when the lab industry’s behemoth announced that it would pay $1.1 billion to buy Unilab, by far the largest lab testing company in California. Integration of the two laboratory operations is planned …

Quest Pays $1.1 Billion To Acquire Unilab Corp. Read More »

Ken Freeman Discusses Plans to Integrate AML and Unilab

CEO SUMMARY: Once again, Ken Freeman and Quest Diagnostics Incorporated is altering the national market for clinical laboratory testing. By acquiring American Medical Laboratories and Unilab, the nation’s largest lab company is expanding its presence in California, Nevada, and Washington, DC. In this exclusive interview with THE DARK REPORT, Chairman and CEO Ken Freeman explains …

Ken Freeman Discusses Plans to Integrate AML and Unilab Read More »

HMO Enrollment In Decline; PPOs Capture 48% of Market

ENROLLMENT IN THE NATION’S HMOS has declined in each of the last two years. Experts now believe the heyday of the classic closed-panel, gatekeeper model of the HMO has ended. “HMOs are in full retreat,” observed Bryant Armstrong, a healthcare consultant in the Dallas office of Hewitt Associates. “They are not dead by any means. …

HMO Enrollment In Decline; PPOs Capture 48% of Market Read More »

Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs

ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On the sell side, American Medical Laboratories and Unilab have been acquired by Quest Diagnostics. The largest remaining …

Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs Read More »

“April 22, 2002 Intelligence: Late Breaking Lab News”

Careside, Inc.’s point-of-care instruments for routine chemistry and hematology are moving into the clinical marketplace. (See TDR, November 22, 1999.) Through January, the company, based in Culver City, California, had placed 73 units, with another 17 on order. Careside’s marketing strategy is to emphasize sales of these instruments to physician office settings rather than hospitals. …

“April 22, 2002 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.